A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...
The Brighterside of News on MSN4d
Breakthrough new treatment developed for retinitis pigmentosaInherited eye disorders such as retinitis pigmentosa (RP) leave millions grappling with progressive vision loss. At the heart ...
Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The ...
Two compounds prolonged the survival of photoreceptors in a retinitis pigmentosa mouse model for rod opsin misfolding ...
Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited form of blindness, has prompted the biotech to seek discussions with regulators about the design ...
The FDA granted rare pediatric disease designation to VG901 for the treatment of retinitis pigmentosa caused by mutations in ...
Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...
It's founded in support of their son, Luke, who is battling Retinitis Pigmentosa ... more vision that he won’t be a candidate for the type of trial we’re trying to get him into," said ...
Monday announced safety and efficacy update for the Phase 1/2 OCU400 clinical trial for the treatment of early ...
OCU400 demonstrated meaningful improvement of 2-line gain (10 letters on ETDRS chart) in low-luminance visual acuity (LLVA) ...
VG901 received FDA Rare Pediatric Disease Designation, potentially qualifying for a priority review voucher upon marketing ...
A multidisciplinary team of researchers from the Istituto Italiano di Tecnologia (IIT-Italian Institute of Technology) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback